InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) traded at $0.59 at last check on Friday, Nov 20, making an upward move of 3.1% on its previous day’s price.
Looking at the stock we see that its previous close was $0.57 and the beta (5Y monthly) reads 1.8 with the day’s price range being $0.5620 – 0.6189. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, NVIV has a high of $11.98 and a low of $0.5. The company’s stock has gained about -1.28% over that past 30 days.
On the other hand, looking at the outlook for the NVIV stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Let’s briefly compare InVivo (NVIV) stock to its peers. We find that today’s price change of +3.1% and -88.28% over the past 12 months for NVIV competes that of Abbott Laboratories (ABT), which has seen its stock price fall -0.1% in the latest trading session and is +32.52% over the last one year. Another of its peers Medtronic Inc (MDT) has dropped -0.76% today, but is -0.3% down over the past year, while Stryker Corp (SYK) is also up 3.1% yet its price remains in the red at -88.28% over the same period. Abbott has a P/E ratio of 58.98 compared to InVivo’s 0 and Medtronic’s 33.99. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), we note that the average 3-month trading volume was 774.33 Million, while that of the preceding 10-day period stands at 943.01 Million. Current shares outstanding are 21.17 Million.
According to data from Thomson Reuters, insiders hold 12.35% of the company’s shares while institutions hold 7.09%. The data shows that short shares as of October 29, 2020, stood at 367.93 Million at a short ratio of 0.25. This represents a 2.21% Short interest in Shares outstanding on October 29, 2020. Shares short rose in October from the previous month at 263.1 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -91.22% down in year-to-date price movement.